Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and based on the intimation received from the Company’s Registrar and Share Transfer Agent (‘RTA’) CIL Securities, Godavari Drugs has informed that the Company has received a letter from the shareholder(s) Jugal Kishore Jaju regarding loss of share certificate(s) with a request for issue of duplicate share certificate(s) in lieu thereof. Further, any person who has a claim in respect of the said securities should lodge such claim with the Company at the registered office, within 15 days from this date. Pursuant to SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated January 25, 2022, the Company/Registrar and Share Transfer Agent shall issue 'Letter of Confirmation' to the shareholder /rightful owner after completion of required formalities. Further details are enclosed.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |